Agile Therapeutics, Inc. (NASDAQ:AGRX) Q4 2023 Earnings Call Transcript

17d ago, source: Hosted on MSN

Agile Therapeutics, Inc. (NASDAQ:AGRX) Q4 2023 Earnings Call Transcript March 28, 2024 Agile Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.46 EPS, expectations were $-0.92.

Why Agile Therapeutics (AGRX) Stock Is Down 60%

on MSN ago, source:

Agile Therapeutics Inc (OTC:AGRX) shares are trading lower by 61% to $0.24 during Tuesday’s session after the company ...

Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update

22d ago, source: Nasdaq

PRINCETON, N.J., March 28, 2024 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Pink: AGRX), a women's healthcare company, today reported financial results for the three and twelve months ended ...

Agile Therapeutics Inc AGRX

22d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Agile Therapeutics: Q4 Earnings Snapshot

22d ago, source: The Washington Post

PRINCETON, N.J. — PRINCETON, N.J. — Agile Therapeutics Inc. (AGRX) on Thursday reported a loss of $4.5 million in its fourth quarter. On a per-share basis, the Princeton, New Jersey-based ...

Agile Therapeutics, Inc.: Agile Therapeutics Announces Delisting from Nasdaq

24d ago, source: Finanznachrichten

PRINCETON, N.J., March 25, 2024 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) ("Agile Therapeutics" or the "Company"), a women's healthcare company ...

Agile Therapeutics, Inc. (NASDAQ:AGRX) Q4 2023 Earnings Call Transcript

18d ago, source: Insider Monkey

Agile Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.46 EPS, expectations were $-0.92. AGRX isn’t one of the 30 most popular stocks among hedge funds at the end of the ...

Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update

22d ago, source: Business Insider

Agile Therapeutics, Inc. (Pink: AGRX), a women's healthcare company, today reported financial results for the three and twelve months ended December 31, 2023 and provided a corporate update.

Agile Therapeutics, Inc. (AGRX) Q4 2023 Earnings Call Transcript

22d ago, source: Seeking Alpha

Good morning, and welcome to the Agile Therapeutics Fourth Quarter and Full Year 2023 Financial Results Conference Call. Please note, today’s event is being recorded. I would now like to turn ...

Q4 2023 Agile Therapeutics Inc Earnings Call

21d ago, source: Yahoo Finance

Matthew Riley; Head of Investor Relations, Corporate Communications; Agile Therapeutics Inc Al Altomari; Chair & Chief Executive Officer; Agile Therapeutics Inc Operator Good morning, and welcome ...